Long Ideas

Apple Inc. (AAPL) Gearing Up to Trounce Expectations, Twitter Inc (TWTR) Enhances Live-Video Advantage

Everyone is talking about Apple Inc.’s (NASDAQ:AAPL) forthcoming iPhone 8 launch- but word on the Street has it that the tech giant’s performance …

Amazon.com, Inc. (AMZN): Apparel Creates Significant Opportunity

As Amazon.com, Inc.

Is Flexion Therapeutics Inc (FLXN) M&A Buzz Just a Dream?

Flexion Therapeutics Inc (NASDAQ:FLXN) investors have sent shares racing 38% on back of media buzz painting the arc of a prospective takeout, courtesy …

Top Analysts See Massive Industry Potential for Advanced Micro Devices, Inc. (AMD) and NVIDIA Corporation (NVDA)

Two of Wall Street’s best-performing analysts are out with glimmering forecasts on two leading chip giants: Advanced Micro Devices, Inc. (NASDAQ:AMD) and NVIDIA …

Not Being Bullish on Facebook Inc (FB) a Big Mistake, Snap Inc (SNAP) Gets One of its First Buys

It’s an interesting day for the tech investor, as Facebook Inc (NASDAQ:FB) receives a vote of confidence from an analyst who regrets ever straying from the FB …

Examining Apple Inc.’s (AAPL) New Online Store Updates, Previewing Micron Technology, Inc. (MU) Ahead of Earnings

Apple Inc. (NASDAQ:AAPL) is “spring cleaning” its online store, welcoming Apple enthusiasts to a fresh line of both products as well as product …

What to Expect from Gilead Sciences, Inc. (GILD) Amid M&A Buzz and Upcoming Catalysts

Analysts see an interesting path ahead for Gilead Sciences, Inc. (NASDAQ:GILD), between exciting collaborative possibilities and its pipeline catalysts that have brought bullish …

A Glimpse Into Apple Inc.’s (AAPL) 3D Upgrade and Micron Technology, Inc.’s (MU) DRAM Pricing Challenges

Is Apple Inc. (NASDAQ:AAPL) at the forefront of 3D technology and are Micron Technology, Inc.

Wall Street Cheers These Two Rising Stocks: Esperion Therapeutics Inc (ESPR) and Nektar Therapeutics (NKTR)

Esperion Therapeutics Inc (NASDAQ:ESPR) and Nektar Therapeutics (NASDAQ:NKTR) are skyrocketing with a fury today on back of major clinical strides forward that have investors …

H.C. Wainwright Slashes Catabasis Pharmaceuticals Inc (CATB) Price Target in Half, But Sticks with Buy Rating

Catabasis Pharmaceuticals Inc (NASDAQ:CATB) shares are falling almost 8% amid an unfortunate setback with the firm’s MoveDMD Part B data read-out that failed …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts